Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
SiChuan Qian Li Beoka Medical Technology Co (BJSE:920199) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
SiChuan Qian Li Beoka Medical Technology Co's EV-to-EBIT for today is
SiChuan Qian Li Beoka Medical Technology Co's current Enterprise Value is ¥1,886.7 Mil.
SiChuan Qian Li Beoka Medical Technology Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥6.3 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
SiChuan Qian Li Beoka Medical Technology Co's EV-to-EBITDA for today is:
SiChuan Qian Li Beoka Medical Technology Co's current Enterprise Value is ¥1,886.7 Mil.
SiChuan Qian Li Beoka Medical Technology Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥6.3 Mil.
SiChuan Qian Li Beoka Medical Technology Co's current Enterprise Value is ¥1,886.7 Mil.
SiChuan Qian Li Beoka Medical Technology Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥272.9 Mil.
SiChuan Qian Li Beoka Medical Technology Co's current Enterprise Value is ¥1,886.7 Mil.
SiChuan Qian Li Beoka Medical Technology Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥7.0 Mil.
SiChuan Qian Li Beoka Medical Technology Co's current Enterprise Value is ¥1,886.7 Mil.
SiChuan Qian Li Beoka Medical Technology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-63.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SiChuan Qian Li Beoka Medical Technology Co Enterprise Value Related Terms
SiChuan Qian Li Beoka Medical Technology Co Enterprise Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SiChuan Qian Li Beoka Medical Technology Co Enterprise Value Chart
SiChuan Qian Li Beoka Medical Technology Co Annual Data
BJSE:920199 vs ABT, SYK, MDT: Enterprise Value Comparison
For the Medical Devices subindustry, SiChuan Qian Li Beoka Medical Technology Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SiChuan Qian Li Beoka Medical Technology Co Enterprise Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SiChuan Qian Li Beoka Medical Technology Co's Enterprise Value distribution charts can be found below:
* The bar in red indicates where SiChuan Qian Li Beoka Medical Technology Co's Enterprise Value falls into.
SiChuan Qian Li Beoka Medical Technology Co Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of ¥1,886.7 Mil mean?
SiChuan Qian Li Beoka Medical Technology Co (BJSE:920199) has a Enterprise Value of ¥1,886.7 Mil as of Aug. 18, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on SiChuan Qian Li Beoka Medical Technology Co and its competitors.
Is SiChuan Qian Li Beoka Medical Technology Co's Enterprise Value too high?
SiChuan Qian Li Beoka Medical Technology Co's current Enterprise Value is ¥1,886.7 Mil. Overall, SiChuan Qian Li Beoka Medical Technology Co has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SiChuan Qian Li Beoka Medical Technology Co's Enterprise Value compare to ABT and SYK?
SiChuan Qian Li Beoka Medical Technology Co's Enterprise Value of ¥1,886.7 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Devices & Instruments company?
A good Enterprise Value depends on the Medical Devices & Instruments industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on SiChuan Qian Li Beoka Medical Technology Co and its competitors. SiChuan Qian Li Beoka Medical Technology Co's current Enterprise Value is ¥1,886.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SiChuan Qian Li Beoka Medical Technology Co stock overvalued right now?
Based on GuruFocus' analysis, SiChuan Qian Li Beoka Medical Technology Co (BJSE:920199) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥17.98, compared to a current price of ¥27.12 — trading 50.8% above its estimated fair value. The current Enterprise Value is ¥1,886.7 Mil. SiChuan Qian Li Beoka Medical Technology Co's overall GF Score™ is 57/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For SiChuan Qian Li Beoka Medical Technology Co (BJSE:920199), the current Enterprise Value is ¥1,886.7 Mil as of Aug. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SiChuan Qian Li Beoka Medical Technology Co (BJSE:920199) Overvalued in 2026?
Based on GuruFocus' analysis, SiChuan Qian Li Beoka Medical Technology Co stock appears to be overvalued.
The current stock price of ¥27.12 is trading 50.8% above its estimated GF Value™ of ¥17.98.
GuruFocus considers SiChuan Qian Li Beoka Medical Technology Co to be Significantly Overvalued.
Key valuation signals for BJSE:920199:
Enterprise Value: ¥1,886.7 Mil
GF Value™: ¥17.98 vs. price of ¥27.12 (50.8% above fair value)
No single metric tells the full story. See the BJSE:920199 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SiChuan Qian Li Beoka Medical Technology Co Ltd is an intelligent rehabilitation equipment manufacturer integrating research, development, production, sales, and service. Its product series comprises the Electrotherapy series, Heat therapy series, Force therapy series, Spa series, and Oxygen therapy series.
57GF Score
Get the complete analysis for BJSE:920199
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920199 has been successfully added to your 
